Innolake Biopharm Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 9

Innolake Biopharm General Information

Description

Developer of therapeutic drugs designed to overcome tumors and immune system diseases. The company offers research and development of therapeutic drugs and operates extensive product development pipelines, thereby enabling patients to receive better treatment and improve their health conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3-6F, Building 24, Yinhai Sci-Tech Innovation Center
  • 501 Fucheng Road, Xiasha Street Qiantang District
  • Hangzhou, Zhejiang 310018
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3-6F, Building 24, Yinhai Sci-Tech Innovation Center
  • 501 Fucheng Road, Xiasha Street Qiantang District
  • Hangzhou, Zhejiang 310018
  • China
+86 021

Innolake Biopharm Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innolake Biopharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 24-Oct-2025 Completed Generating Revenue
3. Early Stage VC (Series B) 05-Feb-2024 Completed Generating Revenue
2. Early Stage VC (Series A1) 04-Jun-2023 $14.3M $60.1M Completed Generating Revenue
1. Early Stage VC 27-Apr-2021 $45.9M $45.9M Completed Generating Revenue
To view Innolake Biopharm’s complete valuation and funding history, request access »

Innolake Biopharm Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Haiwang Capital Venture Capital Minority
Shanghai Science & Technology Investment Venture Capital Minority
Heda Ventures Venture Capital Minority
WuXi Biologics Corporation Minority
Y.R.Delta Fund Growth/Expansion Minority
You’re viewing 5 of 9 investors. Get the full list »

Innolake Biopharm FAQs

  • When was Innolake Biopharm founded?

    Innolake Biopharm was founded in 2020.

  • Where is Innolake Biopharm headquartered?

    Innolake Biopharm is headquartered in Hangzhou, China.

  • What industry is Innolake Biopharm in?

    Innolake Biopharm’s primary industry is Drug Discovery.

  • Is Innolake Biopharm a private or public company?

    Innolake Biopharm is a Private company.

  • What is Innolake Biopharm’s current revenue?

    The current revenue for Innolake Biopharm is .

  • How much funding has Innolake Biopharm raised over time?

    Innolake Biopharm has raised $60.1M.

  • Who are Innolake Biopharm’s investors?

    Haiwang Capital, Shanghai Science & Technology Investment, Heda Ventures, WuXi Biologics, and Y.R.Delta Fund are 5 of 9 investors who have invested in Innolake Biopharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process